fbpx
Home / COVID-19 Coverage / URMC testing antiviral drug to treat COVID-19 patients

URMC testing antiviral drug to treat COVID-19 patients

The University of Rochester Medical Center announced today its participation in a clinical trial sponsored by the National Institute of Health to evaluate the safety and effectiveness of antiviral drug remdesivir for adult patients hospitalized with COVID-19. Ann Falsey M.D. and Angela Branche M.D. lead the study alongside the URMC Vaccine Trials and Evaluation Unit (VTEU). Remdesivir ...

Leave a Reply

Your email address will not be published.

x

Check Also

ur-library-web

UR settles sexual harassment suit for $9.4 million (access required)

The University of Rochester Medical Center announced today its participation in a clinical trial sponsored by the National Institute of ...